134 related articles for article (PubMed ID: 16872571)
21. Confirmation of recent heroin abuse: Accepting the challenge.
Maas A; Madea B; Hess C
Drug Test Anal; 2018 Jan; 10(1):54-71. PubMed ID: 28681463
[TBL] [Abstract][Full Text] [Related]
22. Chemiluminescence detection of heroin in illicit drug samples.
Terry JM; Smith ZM; Learey JJ; Shalliker RA; Barnett NW; Francis PS
Talanta; 2013 Nov; 116():619-25. PubMed ID: 24148453
[TBL] [Abstract][Full Text] [Related]
23. Distinguishing between Contact and Administration of Heroin from a Single Fingerprint using High Resolution Mass Spectrometry.
Costa C; Ismail M; Stevenson D; Gibson B; Webb R; Bailey M
J Anal Toxicol; 2020 Apr; 44(3):218-225. PubMed ID: 31711209
[TBL] [Abstract][Full Text] [Related]
24. Validation of meconin as a marker for illicit opiate use.
Morley SR; Forrest AR; Galloway JH
J Anal Toxicol; 2007 Mar; 31(2):105-8. PubMed ID: 17536746
[TBL] [Abstract][Full Text] [Related]
25. Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology.
Daniulaityte R; Carlson RR; Juhascik MP; Strayer KE; Sizemore IE
Int J Drug Policy; 2019 Sep; 71():3-9. PubMed ID: 31146200
[TBL] [Abstract][Full Text] [Related]
26. Time of day of methadone consumption and illicit heroin use.
Best D; Gossop M; Marsden J; Farrell M; Strang J
Drug Alcohol Depend; 1997 Dec; 49(1):49-54. PubMed ID: 9476699
[TBL] [Abstract][Full Text] [Related]
27. Hair analysis for opiates: hydromorphone and hydrocodone as indicators of heroin use.
Madry MM; Bosshard MM; Kraemer T; Baumgartner MR
Bioanalysis; 2016 May; 8(9):953-64. PubMed ID: 27067523
[TBL] [Abstract][Full Text] [Related]
28. Parameters for determining the origin of illicit heroin samples.
Narayanaswami K
Bull Narc; 1985; 37(1):49-62. PubMed ID: 4063573
[TBL] [Abstract][Full Text] [Related]
29. Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.
Oiestad EL; Johansen U; Oiestad AM; Christophersen AS
J Anal Toxicol; 2011 Jun; 35(5):280-93. PubMed ID: 21619723
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
31. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers for illicit heroin: a previously unrecognized origin of papaverine.
Seetohul LN; Maskell PD; De Paoli G; Pounder DJ
J Anal Toxicol; 2013 Mar; 37(2):133. PubMed ID: 23316026
[No Abstract] [Full Text] [Related]
33. [Simultaneous determination of 11 opiates in hair by liquid chromatography-tandem mass spectrometry].
Sun YY; Xiang P; Shen M
Yao Xue Xue Bao; 2011 Dec; 46(12):1501-6. PubMed ID: 22375426
[TBL] [Abstract][Full Text] [Related]
34. Towards adherence monitoring using breath or oral fluid as a matrix in a methadone maintenance treatment program for patients with a chronic heroin use disorder: Issues and interpretation of the results.
de Jong LAA; Kloost T; Olyslager EJH; Böttcher M; Wieferink JA; Vossenberg P; Belgers M; Beurmanjer H; de Haan HA
J Anal Toxicol; 2023 Dec; 47(9):842-849. PubMed ID: 37639616
[TBL] [Abstract][Full Text] [Related]
35. Component analysis of illicit heroin samples with GC/MS and its application in source identification.
Zhang D; Shi X; Yuan Z; Ju H
J Forensic Sci; 2004 Jan; 49(1):81-6. PubMed ID: 14979348
[TBL] [Abstract][Full Text] [Related]
36. Detection of methadone, methadone metabolites, and other illicit drugs of abuse in hair of methadone-treatment subjects.
Goldberger BA; Darraj AG; Caplan YH; Cone EJ
J Anal Toxicol; 1998 Oct; 22(6):526-30. PubMed ID: 9788529
[TBL] [Abstract][Full Text] [Related]
37. Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse.
Koster RA; Alffenaar JW; Greijdanus B; VanDernagel JE; Uges DR
Ther Drug Monit; 2014 Apr; 36(2):234-43. PubMed ID: 24071815
[TBL] [Abstract][Full Text] [Related]
38. A rapid method for profiling samples of illicit heroin.
Zhang JX; Chen CY
Drug Test Anal; 2012 Jun; 4(6):530-3. PubMed ID: 22522843
[TBL] [Abstract][Full Text] [Related]
39. Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays.
Spanbauer AC; Casseday S; Davoudzadeh D; Preston KL; Huestis MA
J Anal Toxicol; 2001 Oct; 25(7):515-9. PubMed ID: 11599593
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of an Ion Trap Toxtyper Liquid Chromatography With An Ion Trap Mass Spectrometric Instrument (Toxtyper) for Drug of Abuse Screening in Oral Fluid.
Plecko T; Berbalk K; Wieland E; Shipkova M
Ther Drug Monit; 2018 Oct; 40(5):642-648. PubMed ID: 30212416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
